cadherin-28 Inhibitors

Cadherin-28 inhibitors, as discussed here, encompass a range of chemicals that indirectly impact the function of Cadherin-28 by targeting calcium-dependent adhesion mechanisms, cell signaling pathways, and processes related to viral entry. These inhibitors do not directly bind to or inhibit Cadherin-28 but rather modulate the cellular environment or interfere with upstream or downstream pathways that can ultimately influence Cadherin-28 activity. The calcium chelators BAPTA/AM and EGTA, along with calcium channel blockers like Nifedipine and Verapamil, function primarily by altering intracellular calcium levels. Calcium is a critical cofactor for Cadherin-28's adhesion function, and its modulation can influence cell sorting and adhesion. On the other hand, inhibitors like PD 98059 and GW 5074 target specific kinase pathways (MAPK/ERK and RAF, respectively), indicating a broader approach in modulating cellular processes that may indirectly affect Cadherin-28's role in cell communication and adhesion.

In the context of Cadherin-28's role as a receptor for rhinovirus C, chemicals like Pleconaril, Chlorpromazine, Dynamin Inhibitor I, Dynasore, and Amiloride are significant. These compounds interfere with viral entry and replication processes, such as clathrin-mediated endocytosis and capsid binding, thereby potentially reducing the effectiveness of Cadherin-28 as a viral receptor. Genistein and LY 294002, by inhibiting tyrosine kinase and PI3K pathways respectively, represent a strategy to influence cell signaling that may indirectly impact the functional expression or efficiency of Cadherin-28 in cellular adhesion and sorting. Overall, this broad spectrum of inhibitors highlights the complex interplay between Cadherin-28 and various cellular processes, underscoring the potential for indirect modulation of its function through diverse biochemical pathways.